Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis.
about
Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine ModelsUse of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.Variation between the oral and faecal microbiota in a free-living passerine bird, the great tit (Parus major).Analyses of the probiotic property and stress resistance-related genes of Lactococcus lactis subsp. lactis NCDO 2118 through comparative genomics and in vitro assays.Daikenchuto (TU-100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K.Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis.Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells.Surface Proteins of Lactococcus lactis: Bacterial Resources for Muco-adhesion in the Gastrointestinal Tract.Consumption of Diet Containing Free Amino Acids Exacerbates Colitis in Mice.Previous Ingestion of Lactococcus lactis by Ethanol-Treated Mice Preserves Antigen Presentation Hierarchy in the Gut and Oral Tolerance Susceptibility.Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy.Whey Protein Isolate-Supplemented Beverage, Fermented by BL23 and 138, in the Prevention of Mucositis in MiceFecal microbiota associated with phytohaemagglutinin-induced immune response in nestlings of a passerine bird
P2860
Q28083627-AF549667-ACFE-43DD-8F8A-BCF5808A288DQ33650357-CDB2B94C-A849-4078-AD6A-9676AF601327Q33853145-7B9258D1-CACA-41F6-BAD5-7A277A0AFFADQ36338097-AEF5BA73-6537-4231-B685-7C8B4852731DQ36648890-AAB8FCC6-C595-4749-BD8F-E75C1892D69CQ37640672-DA55571D-2964-413B-9694-2CD348926B0CQ43216438-CF994181-2730-421C-8ABD-73B3F89FBD32Q47094937-4A79CE80-D3AE-45AC-9C11-9E2D07599806Q47325652-33BC61B6-E0FE-4638-BE3D-EB1F4B41C853Q47680055-0184FB47-340A-4341-B525-3FB3BDB2688BQ49444745-25487E14-BF03-41D6-8594-ABEBFC4A736BQ57108502-E043B230-6C40-4416-9D3E-25AEDB2F49EDQ58553370-3228F9FA-5030-44C2-94FD-4205DE7CB345
P2860
Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Anti-inflammatory effects of L ...... of chemically induced colitis.
@ast
Anti-inflammatory effects of L ...... of chemically induced colitis.
@en
Anti-inflammatory effects of L ...... of chemically induced colitis.
@nl
type
label
Anti-inflammatory effects of L ...... of chemically induced colitis.
@ast
Anti-inflammatory effects of L ...... of chemically induced colitis.
@en
Anti-inflammatory effects of L ...... of chemically induced colitis.
@nl
prefLabel
Anti-inflammatory effects of L ...... of chemically induced colitis.
@ast
Anti-inflammatory effects of L ...... of chemically induced colitis.
@en
Anti-inflammatory effects of L ...... of chemically induced colitis.
@nl
P2093
P2860
P356
P1433
P1476
Anti-inflammatory effects of L ...... of chemically induced colitis.
@en
P2093
Adna Luciana Sousa
Ana Cristina Gomes-Santos
Anderson Miyoshi
Clarissa Santos Rocha
Denise Carmona Cara
Déborah Nogueira Cruz
Jean Guy LeBlanc
Kátia Moraes
Luísa Lemos
Marcela de Azevedo
P2860
P2888
P356
10.1186/1757-4749-6-33
P577
2014-07-29T00:00:00Z
P5875
P6179
1021145741